Multi-Drug-Resistant Diarrheagenic Escherichia coli Pathotypes in Pediatric Patients with Gastroenteritis from Central Iran

被引:23
|
作者
Abbasi, Elnaz [1 ]
Mondanizadeh, Mahdieh [2 ]
van Belkum, Alex [3 ]
Ghaznavi-Rad, Ehsanollah [4 ,5 ]
机构
[1] Arak Univ Med Sci, Fac Med, Dept Microbiol & Immunol, Arak, Iran
[2] Arak Univ Med Sci, Fac Med, Dept Biotechnol & Mol Med, Arak, Iran
[3] BioMerieux, Data Analyt Dept, La Balme Les Grottes, France
[4] Arak Univ Med Sci, Mol & Med Res Ctr, Fac Med, Arak, Iran
[5] Arak Univ Med Sci, Arak Sch Paramed, Dept Med Lab Sci, Arak, Iran
来源
关键词
diarrheagenic Escherichia coli pathotypes; pediatrics; diarrhea; antibiotic resistance; MDR; Iran; ANTIMICROBIAL RESISTANCE; CHILDREN; SHIGELLA; ETIOLOGY; AGE;
D O I
10.2147/IDR.S247732
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Diarrheagenic Escherichia coli (DEC) is a significant cause of gastroenteritis and a major public health problem. This study investigates the prevalence and the antibiotic resistance patterns of DEC that were isolated from infectious diarrhea samples of pediatric patients from central Iran. Patients and Methods: Pediatric diarrhea samples were collected from 230 pediatric patients visiting the hospital. E. coli pathotypes were diagnosed by using conventional culture methods and PCR. Antibiotic resistance profiles, the frequency of multi-drug resistance (MDR), and the phenotypic and genotypic characteristics of extended spectrum-beta-lactamase (ESBL), AmpC and integron-associated genes were analyzed. Results: Of the 230 samples of infectious diarrhea, 91 (39.5%) produced E. coli isolates. Of these, 32 cases (35.1%) were identified as DEC by culture and PCR. The frequency of the E. coli pathotypes obtained was as follows: EAEC 11/32 (34.3%), EPEC 9/32 (28.1%), ETEC 6/32 (18.7%), EIEC 3/32 (9.3%), and EHEC 3/32 (9.3%). The antibiotic resistance rates were greater for nalidixic acid (30/32; 93.7%), ampicillin (29/32; 90.6%), and tetracycline (25/32; 78.1%) than for any of the other tested antibiotics. High levels of MDR (25/32; 78.1%) and the presence of ESBL (18/32; 56.2%) and AmpC (9/32; 28.1%) were observed in the DEC isolates. The isolates showed a higher frequency of the ESBL genes [bla(TEM) (18/18; 100%), bla(CTX-M15) (17/18; 94.4%)], and AmpC [bla(CIT) (4/9; 44.4%) and bla(DHA) (4/9; 44.4%)] than of the other ESBL and AmpC genes. Conclusion: Compared to the previous study, DEC appeared to be the second-most abundant agent of diarrhea in pediatric patients after Campylobacter jejuni, with frequent MDR and ESBL presence.
引用
下载
收藏
页码:1387 / 1396
页数:10
相关论文
共 50 条
  • [31] Occurrence of Multi-Drug-Resistant Escherichia coli in Chickens, Humans, Rodents and Household Soil in Karatu, Northern Tanzania
    Sonola, Valery S.
    Katakweba, Abdul S.
    Misinzo, Gerald
    Matee, Mecky I. N.
    ANTIBIOTICS-BASEL, 2021, 10 (09):
  • [32] Prevalence of plasmid-encoded carbapenemases in multi -drug resistant Escherichia coli from patients with urinary tract infection in northern Iran
    Paskeh, Mahshid Deldar Abad
    Moghaddam, Mohammad Javad Mehdipour
    Salehi, Zivar
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 23 (05) : 586 - 593
  • [33] Incidence of Diarrheagenic Escherichia coli Pathotypes in Children Suffering from Diarrhea in Tertiary Care Hospitals, Quetta, Pakistan
    Zil-e-Huma
    Tareen, Abdul Malik
    Ullah, Kaleem
    Asmat, Tauseef M.
    Samad, Abdul
    Iqbal, Asim
    Mustafa, Mohammad Zahid
    Ahmad, Irshad
    Rahman, Sadeeq Ur
    PAKISTAN JOURNAL OF ZOOLOGY, 2019, 51 (06) : 2015 - 2021
  • [34] In vitro assessment of the antibacterial effects of the combinations of fosfomycin, colistin, trimethoprim and nitrofurantoin against multi-drug-resistant Escherichia coli
    Abu El-Wafa, W. Mohamed
    Abouwarda, A. M.
    LETTERS IN APPLIED MICROBIOLOGY, 2022, 74 (03) : 334 - 343
  • [35] Phenotypic and genotypic characterization of multi-drug-resistant Escherichia coli isolates harboring blaCTX-M group extended-spectrum β-lactamases recovered from pediatric patients in Shenzhen, southern China
    Patil, Sandip
    Chen, Xiaowen
    Lian, Ma
    Wen, Feiqiu
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 1325 - 1332
  • [36] Diarrheagenic Escherichia coli in Human Immunodeficiency Virus (HIV) Pediatric Patients in Lima, Peru
    Medina, Anicia M.
    Rivera, Fulton P.
    Romero, Liliana M.
    Kolevic, Lenka A.
    Castillo, Maria E.
    Verne, Eduardo
    Hernandez, Roger
    Mayor, Yovanna E.
    Barletta, Francesca
    Mercado, Erik
    Ochoa, Theresa J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (01): : 158 - 163
  • [37] Enteroinvasive Escherichia coli isolated from Egyptian children with acute gastroenteritis are multi-drug resistant and encode for multiple virulence factors
    Nada, Rania A.
    Mohran, Zaynab
    Klena, John D.
    Mostaafa, Sohair A.
    Shaheen, Hind I.
    Putnam, Shannon D.
    Riddle, Mark S.
    Monteville, Marshall R.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 84 - 84
  • [38] Pathotypes and Drug Susceptibility of Escherichia coli Isolated from Companion Dogs in Japan
    Takagi, Hirotaka
    Yamane, Kunikazu
    Matsui, Mari
    Suzuki, Satowa
    Ito, Kenichiro
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2020, 73 (03) : 253 - 255
  • [39] Antimicrobial Efficacy of Green Synthesized Nanosilver with Entrapped Cinnamaldehyde against Multi-Drug-Resistant Enteroaggregative Escherichia coli in Galleria mellonella
    Ram, Vemula Prasastha
    Yasur, Jyothsna
    Abishad, Padikkamannil
    Unni, Varsha
    Gourkhede, Diksha Purushottam
    Nishanth, Maria Anto Dani
    Niveditha, Pollumahanti
    Vergis, Jess
    Malik, Satya Veer Singh
    Kullaiah, Byrappa
    Kurkure, Nitin Vasantrao
    Ramesh, Chatragadda
    Dufosse, Laurent
    Rawool, Deepak B.
    Barbuddhe, Sukhadeo B.
    PHARMACEUTICS, 2022, 14 (09)
  • [40] Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli
    Malik, Shikha
    Nehra, Kiran
    Rana, J. S.
    VIRUS RESEARCH, 2021, 302